AI Verdict
MCS has stronger fundamentals based on our AI analysis.
MDCE vs MCS Fundamental Comparison
| Metric | MDCE | MCS |
|---|---|---|
| Revenue | N/A | $758.5M |
| Net Income | $-6.8M | $12.7M |
| Net Margin | N/A | 1.7% |
| ROE | N/A | 2.8% |
| ROA | -586.3% | 1.3% |
| Current Ratio | 0.16x | 0.40x |
| Debt/Equity | N/A | 0.35x |
| EPS | N/A | $0.77 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MDCE vs MCS: Frequently Asked Questions
Is MDCE or MCS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MCS has stronger fundamentals. MDCE is rated STRONG SELL (95% confidence) while MCS is rated SELL (75% confidence). This is not investment advice.
How does MDCE compare to MCS fundamentally?
Medical Care Technologies Inc. has ROE of N/A vs MARCUS CORP's 2.8%. Net margins are N/A vs 1.7% respectively.
Which stock pays higher dividends, MDCE or MCS?
MDCE has a dividend yield of N/A or no dividend while MCS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MDCE or MCS for long term?
For long-term investing, consider that MDCE has STRONG SELL rating with 95% confidence, while MCS has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MDCE vs MCS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDCE vs MCS, the AI consensus favors MCS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.